CORT

Q: What is the price of Corcept Therapeutics (CORT) today?

The price of Corcept Therapeutics (CORT) today is R$ 377,07, with a variation of 98.77% compared to the last year. The price of Corcept Therapeutics (CORT) started the year trading around R$ 273,11 and today it is at R$ 377,07. Follow the real-time price chart, the historical price of Corcept Therapeutics (CORT), and stock data from Ibovespa and international markets.

Q: When does Corcept Therapeutics (CORT) pay dividends?

Corcept Therapeutics (CORT) did not distribute dividends in the last year.

Q: Corcept Therapeutics (CORT) is it worth it?

Currently, Corcept Therapeutics (CORT) is priced at R$ 377,07, with a P/E of 54,72%, representing a deviation of 33,94% from its historical average P/E. In the last year, the stock showed a variation of 98.77% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 98,77%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Corcept Therapeutics (CORT)?

Investing in shares of Corcept Therapeutics (CORT) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Corcept Therapeutics (CORT) yield today?

The yield of Corcept Therapeutics (CORT) was 1,87% in the last month, 98,77% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Corcept Therapeutics (CORT) today, the total investment would be based on the current price of R$ 377,07.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 74.950,08In 5 years: R$ 37.706,94In 10 years: 37.706,94It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Corcept Therapeutics Incorporated

Price

US$ 69,57

variation (12m)

98,77%

p/l

54,72

p/vp

11,50

DIVIDEND YIELD

0,00%

quote CORT

BVMF

CORT

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of CORT

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

1,87%

3 months

-10,41%

1 year

98,77%

2 years

119,26%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

1,87%

3 months

-10,86%

1 year

88,86%

2 years

99,86%

5 years

0,00%

10 years

0,00%

Indicators CORT

check out the fundamentals of Corcept Therapeutics shares

P/L

54,72

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

10,21

Sector: 1,99 Industry: 2,90

P/VP

11,50

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

16,67%

Sector: -26,53% Industry: -56,94%

ROE

21,02%

Sector: -31,21% Industry: -45,34%

ROIC

25,25%

Sector: -404,40% Industry: -420,46%

Net Margin

18,67%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

98,37%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

14,24%

Sector: -23,10% Industry: -30,21%

P/EBITDA

70,44

Sector: 0,07 Industry: -2,60

P/EBIT

71,74

Sector: -1,37 Industry: -3,22

P/ASSETS

9,12

Sector: 1,23 Industry: 1,32

VPA

6,11

Sector: 3,66 Industry: 1,68

LPA

1,29

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,79

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

15,14%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

4,74%

Sector: - Industry: -

FAIR PRICE OF Corcept Therapeutics ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 69,57

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-80,86%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

CORT indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%

comparison of CORT with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history CORT dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Corcept Therapeutics

Corcept Therapeutics Incorporated

Average user rating I10

4.0 (1 people)

Estados Unidos

27 years

Foundation: 1998

2004

Year of debut on the stock exchange - 21 years

206

Employees

The Company Corcept Therapeutics Incorporated (Estados Unidos), is listed on Nasdaq with a market value of $ 7,31 Billions, having a net worth of $ 635,79 Milhões.

With a total of 206 employees, the company is listed in the sector of Saúde and categorized in industry of Produtos Farmacêuticos.

In the last 12 months the Company had a revenue of $ 716,08 Milhões, which generated a profit in the amount of $ 133,66 Milhões.

As for its main indicators, the Company has a P/E ratio of 54,72, a P/B ratio of 11,50 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker CORT.

Market value

US$ 7,31 Billions

Net worth

US$ 635,79 Milhões

US$ 635.790.000,00

Assets

US$ 801,72 Milhões

US$ 801.720.000,00

Total Number of Shares

104,00 Milhões

104.000.000

Average Daily Trading Volume

US$ 1,12 Million

US$ 1.122.352,62

Sector

Saúde

Industry

Produtos Farmacêuticos

CORT

CORT revenue and profits

CORT results

DRAG THE FRAME TO SEE MORE DATA

CORT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of Corcept Therapeutics (CORT) today?

The price of Corcept Therapeutics (CORT) today is R$ 377,07, with a variation of 98.77% compared to the last year. The price of Corcept Therapeutics (CORT) started the year trading around R$ 273,11 and today it is at R$ 377,07. Follow the real-time price chart, the historical price of Corcept Therapeutics (CORT), and stock data from Ibovespa and international markets.

When does Corcept Therapeutics (CORT) pay dividends?

Corcept Therapeutics (CORT) did not distribute dividends in the last year.

Corcept Therapeutics (CORT) is it worth it?

Currently, Corcept Therapeutics (CORT) is priced at R$ 377,07, with a P/E of 54,72%, representing a deviation of 33,94% from its historical average P/E. In the last year, the stock showed a variation of 98.77% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 98,77%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Corcept Therapeutics (CORT)?

Investing in shares of Corcept Therapeutics (CORT) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Corcept Therapeutics (CORT) yield today?

The yield of Corcept Therapeutics (CORT) was 1,87% in the last month, 98,77% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Corcept Therapeutics (CORT) today, the total investment would be based on the current price of R$ 377,07.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 74.950,08
In 5 years: R$ 37.706,94
In 10 years: 37.706,94

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CORT

Corcept Therapeutics Incorporated

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of CORT

check out the fundamentals of Corcept Therapeutics shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Corcept Therapeutics

Corcept Therapeutics Incorporated

Estados Unidos

27 years

2004

206

PROFIT X PRICE CORT

CORT results

CORT cash flow

evolution of assets - CORT

CORT balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80